- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Invitation to Presentation of Dignitana’s Third Quarter Interim Report
Tele Conference and Participation in Redeye Life Science Day Scheduled for November 19, 2019
Dignitana AB, world leader in scalp cooling innovation, invites you to two shareholder events following the upcoming publication of the Company’s Interim Report. Dignitana will publish its Q3 2019 Interim Report on Tuesday November 19 at 08.30 CET.
A tele conference in English for shareholders, investors, analysts and media is scheduled for November 19 at 09.30-10.00 CET. Dignitana CEO William Cronin will present the Company and comment on the interim report for the period followed by a Q&A session. Please call in a few minutes ahead of the scheduled presentation.
Dial in by using one of the numbers below:
SE: +46 8566 42707
UK: +44 3333 009270
US: 646 722 4904
The same day, Dignitana is featured at the Redeye Life Science Day in Stockholm. At 10.30 CET Dignitana CEO William Cronin will make a presentation of the Company and the Q3 Interim Report followed by a Q&A session by a Redeye analyst. The focus of this presentation is the global roll out of the new DigniCap Delta. The Redeye Life Science Day takes place at ROOTS @ Downtown Camper by Scandic, Drottninggatan 28. The presentations will be webcast and are available at https://www.redeye.se/live/ls-day-2019.
For More Information Contact
Investor Relations +1 469 518 5031 email@example.com
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Erik Penser Bank AB, Certified Adviser, +46 (0) 8 463 83 00 firstname.lastname@example.org www.penser.se Learn more at www.dignitana.se and www.dignicap.com.